MedPath

Comparison of the efficacy of intravenous papaverin and intravenous ketorolac vs. intravenous ketorolac and placebo in patients with renal colic in Emergency Department

Phase 3
Conditions
Renal colic.
Unspecified renal colic
Registration Number
IRCT20190217042738N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
280
Inclusion Criteria

17CTScan approved renal colic
CV angle tenderness
Pain score >,=4
Satisfaction to participate in the study

Exclusion Criteria

Allergy to Papaverine, Ketorolac, ASA, Ibuprofen
Past history of coronary artery disease, complete heart block, AV block type 2
Renal failure, liver disease, coagulopathy, peptic ulcer disease
Pregnancy & lactation
opium addiction
Dissatisfied to participate in the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visual Analog Scale (VAS) of pain. Timepoint: Before intervention, 20, 45 and 60 min after intervention. Method of measurement: Visual Analog Scale (VAS) of pain.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath